Ranitidine trial
Executive Summary
FDA decision giving Genpharm exclusivity for generic ranitidine was judged incorrect by U.S. federal court in July in a suit filed against FDA by Novopharm subsidiary Granutec ("The Pink Sheet" Feb. 9, T&G-15). Genpharm and Geneva were then able to obtain a stay of the order, preventing final approval of the Novopharm ANDA...